Hypermarcas (OTCMKTS:HYPMY - Get Free Report) declared a dividend on Monday, June 23rd, investing.com reports. Stockholders of record on Tuesday, July 1st will be paid a dividend of 0.0345 per share on Friday, January 8th. This represents a dividend yield of 2.81%. The ex-dividend date is Monday, June 30th.
Hypermarcas Price Performance
Shares of HYPMY traded down $0.10 during midday trading on Thursday, hitting $4.60. The company's stock had a trading volume of 29,144 shares, compared to its average volume of 50,653. Hypermarcas has a one year low of $2.64 and a one year high of $5.92. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63. The company's fifty day simple moving average is $4.30 and its two-hundred day simple moving average is $3.60. The stock has a market capitalization of $2.91 billion, a price-to-earnings ratio of 19.17 and a beta of 0.79.
Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $184.34 million for the quarter. Hypermarcas had a net margin of 12.51% and a return on equity of 6.95%.
Hypermarcas Company Profile
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
